Menu
Currency
GWAS Study

Genetic determinants of circulating GIP and GLP-1 concentrations.

Almgren P, Lindqvist A, Krus U et al.

29093273 PubMed ID
GWAS Study Type
8249 Participants
111 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

AP
Almgren P
LA
Lindqvist A
KU
Krus U
HL
Hakaste L
OE
Ottosson-Laakso E
AO
Asplund O
SE
Sonestedt E
PR
Prasad RB
LE
Laurila E
OM
Orho-Melander M
MO
Melander O
TT
Tuomi T
HJ
Holst JJ
NP
Nilsson PM
WN
Wierup N
GL
Groop L
AE
Ahlqvist E
Chapter II

Abstract

Summary of the research findings

The secretion of insulin and glucagon from the pancreas and the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) from the gastrointestinal tract is essential for glucose homeostasis. Several novel treatment strategies for type 2 diabetes (T2D) mimic GLP-1 actions or inhibit incretin degradation (DPP4 inhibitors), but none is thus far aimed at increasing the secretion of endogenous incretins. In order to identify new potential therapeutic targets for treatment of T2D, we performed a meta-analysis of a GWAS and an exome-wide association study of circulating insulin, glucagon, GIP, and GLP-1 concentrations measured during an oral glucose tolerance test in up to 7,828 individuals. We identified 6 genome-wide significant functional loci associated with plasma incretin concentrations in or near the SLC5A1 (encoding SGLT1), GIPR, ABO, GLP2R, F13A1, and HOXD1 genes and studied the effect of these variants on mRNA expression in pancreatic islet and on metabolic phenotypes. Immunohistochemistry showed expression of GIPR, ABO, and HOXD1 in human enteroendocrine cells and expression of ABO in pancreatic islets, supporting a role in hormone secretion. This study thus provides candidate genes and insight into mechanisms by which secretion and breakdown of GIP and GLP-1 are regulated.

3,344 Swedish ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

8249
Total Participants
GWAS
Study Type
Yes
Replicated
4,905 Finnish ancestry individuals
Replication Participants
European
Ancestry
Sweden, Finland
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.